Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PA101 in Indolent Systemic Mastocytosis
NCT02478957Phase 2Completed
- Sponsor
- Patara Pharma
- Start
- Jun 2015
- Primary completion
- Mar 2016
- Modality
- Small Molecules
- Countries
- 5
01
Overview
A Phase 2 trial of RVT-1601 in indolent systemic mastocytosis (ISM), sponsored by Patara Pharma. Started Jun 2015; status: completed.
02
Drugs
RVT-1601
03
Conditions
indolent systemic mastocytosis (ISM)
Beyond the preview
Go deeper on NCT02478957.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02478957.